Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura E Bauman

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
JPGN Reports|November 29, 2024
Upadacitinib as salvage therapy in adolescents with acute severe ulcerative colitis refractory to conventional treatmentsAndrew Dickerson, Jeannie S Huang, Laura E Bauman
JPGN Reports|November 17, 2025
Drug-induced liver injury associated with selective androgen receptor modulators in an adolescent patientDavid J Katibian, Laura E Bauman, Katayoon Shayan, et al.
Inflammatory Bowel Diseases|June 11, 2026
Between-visit care represents a substantial and underrecognized component of health care utilization in pediatric inflammatory bowel diseaseJeannie S Huang, Laura E Bauman, David Katibian, et al.
Inflammatory Bowel Diseases|July 10, 2019
Improved Population Pharmacokinetic Model for Predicting Optimized Infliximab Exposure in Pediatric Inflammatory Bowel DiseaseLaura E Bauman, Ye Xiong, Tomoyuki Mizuno, et al.
Hepatology Communications|November 20, 2025
Neighborhood disparities and metabolic dysfunction-associated steatotic liver disease in children with overweight or obesityAnanya Venkatesh, Nhat Thai, Patricia Ugalde-Nicalo, et al.
Inflammatory Bowel Diseases|May 26, 2020
Effect of a Practice-wide Anti-TNF Proactive Therapeutic Drug Monitoring Program on Outcomes in Pediatric Patients with Inflammatory Bowel DiseaseJohn L Lyles, Aditi A Mulgund, Laura E Bauman, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
JPGN Reports|November 29, 2024
Upadacitinib as salvage therapy in adolescents with acute severe ulcerative colitis refractory to conventional treatmentsAndrew Dickerson, Jeannie S Huang, Laura E Bauman
JPGN Reports|November 17, 2025
Drug-induced liver injury associated with selective androgen receptor modulators in an adolescent patientDavid J Katibian, Laura E Bauman, Katayoon Shayan, et al.
Inflammatory Bowel Diseases|June 11, 2026
Between-visit care represents a substantial and underrecognized component of health care utilization in pediatric inflammatory bowel diseaseJeannie S Huang, Laura E Bauman, David Katibian, et al.
Inflammatory Bowel Diseases|July 10, 2019
Improved Population Pharmacokinetic Model for Predicting Optimized Infliximab Exposure in Pediatric Inflammatory Bowel DiseaseLaura E Bauman, Ye Xiong, Tomoyuki Mizuno, et al.
Hepatology Communications|November 20, 2025
Neighborhood disparities and metabolic dysfunction-associated steatotic liver disease in children with overweight or obesityAnanya Venkatesh, Nhat Thai, Patricia Ugalde-Nicalo, et al.
Inflammatory Bowel Diseases|May 26, 2020
Effect of a Practice-wide Anti-TNF Proactive Therapeutic Drug Monitoring Program on Outcomes in Pediatric Patients with Inflammatory Bowel DiseaseJohn L Lyles, Aditi A Mulgund, Laura E Bauman, et al.
Pageof 1